Radio and PodcastRadio and PodcastLive Radio & Podcasts
VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators artwork
Science & Medicine

VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators

Blood Podcast by American Society of Hematology

Jan 1, 202614:53Science & Medicine

In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of...

About This Episode

VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators is an episode from Blood Podcast by American Society of Hematology. In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Seh...

Podcast

This episode belongs to Blood Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jan 1, 2026, 14:53 long, audio available.

Questions About This Episode

What is VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators about?

In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study supplemented by transcriptome and Mendelian randomization analyses to identify 28 loci and proteins associated with VTE recurrence risk. This work provides genomic evidence that inherited variants contribute to the risk of VTE recurrence, raising the possibility of a more personalized approach to the prevention of recurrent VTE. The study conducted by Dr. Schetelig and colleagues report the results of a long term trial on patients with poor-response AML, comparing outcomes between patients who received salvage chemotherapy versus immediate transplantation. With no difference in survival rates at 5 years, outcomes seem to be determined mainly by genetic risk factors, age, and comorbidities, therefore challenging the routine use of intensive remission induction before allogeneic transplant in patients with an available donor and underscore the need for novel therapeutic strategies for poor-risk AML. Featured Articles: Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial

Where can I listen to VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators?

You can listen to VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators from?

VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators is an episode from Blood Podcast by American Society of Hematology.

How long is this episode?

This episode is 14:53 long.

When was this episode published?

This episode was published on Jan 1, 2026.

Can I save VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from Blood Podcast?

Yes. This page shows related episodes from Blood Podcast when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators?

You can listen to VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators is from Blood Podcast by American Society of Hematology.

What are the episode details?

Published Jan 1, 2026 and 14:53 long